Home
News
Create
Screeners
Insights
Biofil Chemicals
35.
85
-1.43
(-3.84%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-3.84%
1M
-9.90%
6M
-26.10%
1Y
-45.63%
5Y
-85.13%
View Company Insights
Latest news about Biofil Chemicals
Biofil Chemicals Reports Profit Turnaround Despite Revenue Decline in Q2 FY2026
Nov 14, 2025
Biofil Chemicals and Pharmaceuticals Limited reported a significant profitability turnaround for Q2 FY2026. Despite a 40.20% year-on-year revenue decline to Rs 199.73 crore, the company posted a net profit of Rs 241.10 crore, compared to a loss of Rs 244.19 crore in the same period last year. The basic and diluted EPS improved to Rs 1.48 from Rs 0.01 in Q2 FY2025. The company's total assets stood at Rs 5,536.35 crore, with total equity of Rs 2,130.43 crore as of September 30, 2025.
Biofil Chemicals Shareholders Overwhelmingly Approve Sale of Industrial Land Leasehold Rights
Sep 15, 2025
Biofil Chemicals Appoints Smitesh Shah as Additional Promoter Director
Aug 23, 2025
Biofil Chemicals And Pharma to Sell Industrial Land for Minimum ₹16 Crore
Aug 04, 2025
Biofil Chemicals to Sell Pithampur Industrial Land for Rs 16 Crore
Aug 04, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation